NO20081704L - Et peptid-immunoglobulin-konjugat - Google Patents

Et peptid-immunoglobulin-konjugat

Info

Publication number
NO20081704L
NO20081704L NO20081704A NO20081704A NO20081704L NO 20081704 L NO20081704 L NO 20081704L NO 20081704 A NO20081704 A NO 20081704A NO 20081704 A NO20081704 A NO 20081704A NO 20081704 L NO20081704 L NO 20081704L
Authority
NO
Norway
Prior art keywords
peptide
immunoglobulin conjugate
peptide immunoglobulin
immunoglobulin
peptides
Prior art date
Application number
NO20081704A
Other languages
English (en)
Norwegian (no)
Inventor
Erhard Kopetzki
Stephan Fischer
Ralf Schumacher
Suryanarayana Sankuratri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081704(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20081704L publication Critical patent/NO20081704L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20081704A 2005-10-21 2008-04-07 Et peptid-immunoglobulin-konjugat NO20081704L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023002 2005-10-21
PCT/EP2006/010061 WO2007045463A1 (en) 2005-10-21 2006-10-19 A peptide-immunoglobulin-conjugate

Publications (1)

Publication Number Publication Date
NO20081704L true NO20081704L (no) 2008-06-05

Family

ID=35809600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081704A NO20081704L (no) 2005-10-21 2008-04-07 Et peptid-immunoglobulin-konjugat

Country Status (13)

Country Link
US (1) US20070148180A1 (pt)
EP (1) EP1940882A1 (pt)
JP (1) JP2009512655A (pt)
KR (1) KR20080070014A (pt)
CN (1) CN101291956A (pt)
AR (1) AR056137A1 (pt)
AU (1) AU2006303438A1 (pt)
BR (1) BRPI0617511A8 (pt)
CA (1) CA2625332A1 (pt)
IL (1) IL190552A0 (pt)
NO (1) NO20081704L (pt)
TW (1) TW200722436A (pt)
WO (1) WO2007045463A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
MX2009012609A (es) 2007-05-22 2009-12-07 Amgen Inc Composiciones y metodos para producir proteinas de fusion bioactivas.
PT2592148T (pt) 2007-10-12 2018-11-12 Hoffmann La Roche Expressão proteica de múltiplos ácidos nucleicos
JP2012521197A (ja) 2009-03-20 2012-09-13 アムジエン・インコーポレーテツド 担体免疫グロブリンおよびその使用
AU2010321832B2 (en) 2009-11-20 2014-08-14 Amgen Inc. Anti-Orai1 antigen binding proteins and uses thereof
US20140072983A1 (en) 2010-08-10 2014-03-13 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
CA2885176C (en) 2010-09-22 2018-10-23 Amgen Inc. Carrier immunoglobulins and uses thereof
WO2012099983A1 (en) 2011-01-18 2012-07-26 Amgen Inc. Nav1.7 knockout mice and uses thereof
BR112014014418A2 (pt) * 2011-12-15 2019-09-24 Nat Res Council Canada proteínas de fusão fc de receptor igf solúvel e usos das mesmas
US20150201588A1 (en) 2012-02-22 2015-07-23 Amgen Inc. Autologous Mammalian Models Derived from Induced Pluripotent Stem Cells and Related Methods
EP3207146B1 (en) 2014-10-15 2021-09-29 Amgen Inc. Promoter and regulatory elements for improved expression of heterologous genes in host cells
WO2018132768A1 (en) 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity
WO2019066603A1 (ko) * 2017-09-29 2019-04-04 한미약품 주식회사 효력이 향상된 지속성 단백질 결합체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
ATE311895T1 (de) * 1992-05-26 2005-12-15 Immunex Corp Neue zytokine die cd30 binden
US6620413B1 (en) * 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
BR9710811A (pt) * 1996-05-22 1999-08-17 Novopharm Biotech Inc Fragmentos de liga-Æo de antigeno que detecta especificamente c-lulas cancerigenas nucleotideos que codificam os fragmentos e o seu uso para a profilaxia e detec-Æo de c-nceres
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
DE60123238T2 (de) * 2000-06-05 2007-05-03 University of Tennessee Corp., Knoxville Zusammensetzungen zur behandlung von autoimmunkrankheiten
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
RU2006128593A (ru) * 2004-01-07 2008-02-20 Тримерис, Инк. (Us) Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека

Also Published As

Publication number Publication date
KR20080070014A (ko) 2008-07-29
BRPI0617511A2 (pt) 2015-07-07
CA2625332A1 (en) 2007-04-26
EP1940882A1 (en) 2008-07-09
US20070148180A1 (en) 2007-06-28
IL190552A0 (en) 2008-11-03
BRPI0617511A8 (pt) 2018-04-24
WO2007045463A1 (en) 2007-04-26
JP2009512655A (ja) 2009-03-26
TW200722436A (en) 2007-06-16
AU2006303438A1 (en) 2007-04-26
AR056137A1 (es) 2007-09-19
CN101291956A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
EP2163562A3 (en) IL-1beta binding antibodies and fragments thereof
CY1119943T1 (el) Πεγκυλιωμενα σακχαρα και γλυκοπεπτιδια διασυνδεδεμενα με γλυκερολη
NZ611324A (en) Il-17 binding proteins
CY1114626T1 (el) Μεθοδοι κυκλοπολυαιθυλενογλυκολιωσης και πρωτεϊνες/πεπτιδια που παραγονται με αυτες τις μεθοδους
WO2008095004A3 (en) Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
EA202191651A1 (ru) Бициклические пептидные лиганды, специфичные к mt1-mmp
NZ625630A (en) Human il-23 antigen binding proteins
BRPI0818288A2 (pt) Proteínas conjugadas e peptídeos.
NZ597168A (en) Dual variable domain immunoglobin and uses thereof
NZ604360A (en) Il-1 binding proteins
MX2020000583A (es) Proteínas de fijación al antígeno que se fijan a 5t4 y 4-1bb y composiciones y métodos relacionados.
WO2003074546A3 (de) Streptavidin-bindungspeptid
WO2008093058A3 (en) Peptides and their use
TW200722436A (en) A peptide-immunoglobulin-conjugate
EP4103585A4 (en) PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS AND THEIR USES
EP4069713A4 (en) NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2007039231A3 (en) Method of producing a modified (poly)peptide
WO2002074787A3 (en) Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules
WO2007016303A3 (en) Unsaturated polyester resin compositions with improved weatherabilty
MX2009009370A (es) Conjugados del complemento de peptido.
EA200870137A1 (ru) Конъюгаты лекарство-полимер
WO2007110772A8 (en) Immunomodulating oligopeptides
EP1691664A4 (en) ANTIBODIES AND / OR THEIR CONJUGATES BINDING TO THE AMINOTERMINAL FRAGMENT OF UROKINASE, COMPOSITIONS AND THEIR USES
WO2008069965A3 (en) Novel genes and proteins that home to developing microvessels

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application